Treating acute and chronic GvHD

This activity is older than 12 months

This patient case series has been developed with the assistance of Prof. Catherine J. Lee (Blood and Marrow Transplant & Cellular Therapy Program, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA) and Dr. Doris M. Ponce (Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA).

The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient.

For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling. Please note that products may have different product labeling according to geographical location. In the USA, full prescribing information is from the US Food and Drug Administration (fda.gov).

All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended for healthcare professionals (HCPs) registered to practice in the USA. To proceed, please confirm that you are an HCP practicing in the USA.

National Comprehensive Cancer Network (NCCN) recommendations included throughout the case are category 2A unless otherwise indicated.

Modules

• A 51-year-old man with multi-organ manifestations post-allogeneic transplant

• A 47-year-old woman with multi-organ cGVHD manifestations post-allogeneic transplant

• A 57-year-old man with skin rash, intermittent nausea, and vomiting post-allogeneic transplant

• A 52-year-old woman with skin rash and diarrhea post-allogeneic transplant